0000899243-21-002729.txt : 20210121 0000899243-21-002729.hdr.sgml : 20210121 20210121180435 ACCESSION NUMBER: 0000899243-21-002729 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210111 FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wittouck Amaury CENTRAL INDEX KEY: 0001841311 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 21543124 MAIL ADDRESS: STREET 1: VALLEY PARK STREET 2: 44, RUE DE LA VALLEE CITY: LUXEMBOURG STATE: N4 ZIP: L2661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-01-11 0 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001841311 Wittouck Amaury VALLEY PARK, 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 LUXEMBOURG 1 0 1 0 Common Stock 32259461 I See Footnotes Common Stock 3516214 I See Footnotes Common Stock 35402689 I See Footnotes On January 11, 2021, the Reporting Person became the sole member of the board of Stichting Administratiekantoor Westend (the "Stichting"), and therefore, may be deemed to beneficially own the securities reported herein. The Reporting Person disclaims beneficial ownership over the securities reported herein, except to the extent of his pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, the Reporting Person states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. These securities are directly held by Artal International S.C.A. These securities are directly held by Invus Public Equities, L.P. These securities are directly held by Invus, L.P. The Reporting Person is the sole member of the board of the Stichting. The Stichting is the majority stockholder of Westend S.A. Westend S.A. is the parent company of Artal Group S.A. Artal Group S.A. is the sole stockholder of Artal International Management S.A., which is the managing partner of Artal International S.C.A. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. and through its Geneva branch is the sole stockholder of Artal Treasury Limited. Artal Treasury Limited is the managing member of Invus Public Equities Advisors, LLC. Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. Invus Partners, LLC directly holds 4,321,214 shares of Issuer common stock. Neither the Reporting Person nor any of the other entities listed in Footnote 5 hereof have any beneficial or pecuniary interest for purposes of Section 16 of the Exchange Act in the shares of Issuer common stock directly held by Invus Partners, LLC. For purposes of Section 16 of the Exchange Act, the Reporting Person and the other entities listed in Footnote 5 may be deemed to be directors by deputization of the Issuer by virtue of Invus, L.P.'s right to designate certain members of the Issuer's board of directors pursuant to a stockholders' agreement between the Issuer and Invus, L.P. /s/ Amaury Wittouk 2021-01-21